Meyer-Probst B, Vehreschild T
Psychiatr Neurol Med Psychol (Leipz). 1976 Aug;28(8):491-9.
The authors, after typologically defining three etiopathogenetically different forms of lack of concentration power, report the therapeutic effects produced by Aponeuron administered to 38 eight- to thirteen-year-old hyperkinetic children lacking adequate concentration power but being of normal intelligence. The results reported in this paper are based upon comparative psychometric tests, valuation scales used by parents and teachers, and the grades received before and after a three- to six-month treatment. They provide statistical evidence of an increase in concentration power and a decrease in both fatigability and motor unrest. Obviously, objections frequently made to the treatment of encephalopathic children with centrally stimulating drugs are not justified providing indication is furnished expertly.
作者们在从类型学上定义了注意力不集中的三种不同病因形式之后，报告了将Aponeuron应用于38名8至13岁、注意力不集中但智力正常的多动症儿童所产生的治疗效果。本文所报告的结果基于对比心理测量测试、家长和教师使用的评估量表，以及三到六个月治疗前后的成绩。这些结果提供了统计学证据，证明注意力有所提高，疲劳感和运动不安有所减轻。显然，如果能由专家提供用药指征，那么经常有人对用中枢兴奋药治疗脑病儿童提出的反对意见是不合理的。
